This is a phase III, open label, randomized, controlled, multicenter study with two parallel groups of patients.~Tizaspray® 0.5 mg (a new pharmaceutical form, liquid nasal spray solution), is proposed in this trial as a ready to use treatment for short term therapy of painful muscle spasms as the acute low back pain.
Open label, randomized, controlled, multicenter study with two parallel groups of patients